CFTR genotype as a predictor of prognosis in cystic fibrosis

Chest

Volumn 130, Issue 5, 2006, Pages 1441-1447

  McKone, Edward F ^a,b   Goss, Christopher H ^a   Aitken, Moira L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Epidemiology; Genetics; Survival

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ACCURACY; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIAL COLONIZATION; CFTR GENE; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; CYSTIC FIBROSIS; DISEASE SEVERITY; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HIGH RISK PATIENT; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL STATUS; PANCREAS INSUFFICIENCY; PHENOTYPIC VARIATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PSEUDOMONAS AERUGINOSA; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; UNITED STATES;

EID: 33751242495     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.5.1441     Document Type: Article

References (33)

1. Cystic fibrosis mutation database. Available at: www.genet.sickkids.on. ca/cftr/. Accessed July 7, 2006
2. Welsh M, Ramsey B, Accurso F, et al. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The metabolic and molecular basis of inherited disease. New York, NY: McGraw-Hill, Health Professions Division, 2001; 5121-5188
3. Kerem E, Corey M, Kerem BS, et al. The relation between genotype and phenotype in cystic fibrosis: analysis of the most common mutation (ΔF508). N Engl J Med 1990; 323:1517-1522
4. Santis G, Osborne L, Knight RA, et al. Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet 1990; 336:1081-1084
5. Johansen HK, Nir M, Hoiby N, et al. Severity of cystic fibrosis in patients homozygous and heterozygous for ΔF508 mutation. Lancet 1991; 337:631-634
6. Kristidis P, Bozon D, Corey M, et al. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 1992; 50:1178-1184
7. Correlation between genotype and phenotype in patients with cystic fibrosis: the Cystic Fibrosis Genotype-Phenotype Consortium. N Engl J Med 1993; 329:1308-1313
8. Highsmith WE, Burch LH, Zhou Z, et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med 1994; 331:974-980
9. Stern RC, Doershuk CF, Drumm ML. 3849+10 kb C->T mutation and disease severity in cystic fibrosis. Lancet 1995; 346:274-276
10. Gan KH, Veeze HJ, van den Ouweland AM, et al. A cystic fibrosis mutation associated with mild lung disease. N Engl J Med 1995; 333:95-99
11. Highsmith WE Jr, Burch LH, Zhou Z, et al. Identification of a splice site mutation (2789 +5 G > A) associated with small amounts of normal CFTR mRNA and mild cystic fibrosis. Hum Mutat 1997; 9:332-338
12. Tsui LC. The spectrum of cystic fibrosis mutations. Trends Genet 1992; 8:392-398
13. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993; 73:1251-1254
14. McKone EF, Emerson SS, Edwards KL, et al. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 2003; 361:1671-1676
15. Lai HJ, Cheng Y, Cho H, et al. Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis. Am J Epidemiol 2004; 159:537-546
16. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122:1-9
17. Rosenfeld M, Davis R, FitzSimmons S, et al. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997; 145:794-803
18. Mickle JE, Cutting GR. Genotype-phenotype relationships in cystic fibrosis. Med Clin North Am 2000; 84:597-607
19. Koch C, Cuppens H, Rainisio M, et al. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 2001; 31:1-12
20. Burke W, Aitken ML, Chen SH, et al. Variable severity of pulmonary disease in adults with identical cystic fibrosis mutations. Chest 1992; 102:506-509
21. Tzetis M, Efthymiadou A, Doudounakis S, et al. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A->G, 2751+2T->A, 296+1G->C, 1717-9T->C-D565G) and one nonsense mutation (E822X) in the CFTR gene. Hum Genet 2001; 109:592-601
22. Ramalho AS, Beck S, Meyer M, et al. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am J Respir Cell Mol Biol 2002; 27:619-627
23. Accurso FJ, Sontag MK. Seeking modifier genes in cystic fibrosis. Am J Respir Crit Care Med 2003; 167:289-290
24. Gaskin K, Gurwitz D, Durie P, et al. Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr 1982; 100:857-862
25. Ahmed N, Corey M, Forstner G, et al. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 2003; 52:1159-1164
26. Davis PB, Schluchter MD, Konstan MW. Relation of sweat chloride concentration to severity of lung disease in cystic fibrosis. Pediatr Pulmonol 2004; 38:204-209
27. Kerem E, Reisman J, Corey M, et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992; 326:1187-1191
28. Liou TG, Adler FR, Fitzsimmons SC, et al. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001; 153:345-352
29. Mayer-Hamblett N, Rosenfeld M, Emerson J, et al. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med 2002; 166:1550-1555
30. NIH Consensus Development Program. NIH consensus statement: genetic testing for cystic fibrosis. Bethesda, MD: National Institutes of Health, 1997; 15:1-37
31. Kiesewetter S, Macek M Jr, Davis C, et al. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet 1993; 5:274-278
32. Kulczycki LL, Kostuch M, Bellanti JA. A clinical perspective of cystic fibrosis and new genetic findings: relationship of CFTR mutations to genotype-phenotype manifestations. Am J Med Genet 2003; 116:A262-A267
33. Patient registry 2002 annual data report. Bethesda, MD: Cystic Fibrosis Foundation, 2003